vs
Aveanna Healthcare Holdings, Inc.（AVAH）とカーディナルヘルス（BTSG）の財務データ比較。上の社名をクリックして会社を切り替えられます
カーディナルヘルスの直近四半期売上が大きい（$3.6B vs $621.9M、Aveanna Healthcare Holdings, Inc.の約5.7倍）。Aveanna Healthcare Holdings, Inc.の純利益率が高く（2.3% vs 2.2%、差は0.1%）。Aveanna Healthcare Holdings, Inc.の前年同期比売上増加率が高い（22.2% vs 16.3%）。過去8四半期でカーディナルヘルスの売上複合成長率が高い（17.4% vs 14.0%）
Aveanna Healthcare Holdings, Inc.は米国の代表的な在宅・地域密着型医療サービス事業者で、小児在宅看護、成人向け介護、ホスピス、輸液療法などを提供しています。全米に広がる地域ケアセンター網を通じ、公的・民間保険加入者を中心にサービスを提供しています。
カーディナルヘルスは米国の多国籍医療サービス企業で、米国企業収益ランキング第15位に位置し、本社をオハイオ州ダブリンに置く。医薬品・医療製品流通で10万拠点以上にサービスを提供するほか、手術着や手袋、流体管理製品などを製造し、最大級の放射性医薬品ネットワークも運営する。
AVAH vs BTSG — 直接比較
損益計算書 — Q3 2026 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $621.9M | $3.6B |
| 純利益 | $14.1M | $77.1M |
| 粗利率 | 32.6% | 11.6% |
| 営業利益率 | 8.6% | 3.0% |
| 純利益率 | 2.3% | 2.2% |
| 売上前年比 | 22.2% | 16.3% |
| 純利益前年比 | 132.8% | 381.8% |
| EPS（希薄化後） | $0.06 | $0.34 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | — | $3.6B | ||
| Q3 25 | $621.9M | $3.3B | ||
| Q2 25 | $589.6M | $3.1B | ||
| Q1 25 | $559.2M | $2.9B | ||
| Q4 24 | $519.9M | $3.1B | ||
| Q3 24 | $509.0M | $2.9B | ||
| Q2 24 | $505.0M | $2.7B | ||
| Q1 24 | $490.7M | $2.6B |
| Q4 25 | — | $77.1M | ||
| Q3 25 | $14.1M | $55.8M | ||
| Q2 25 | $27.0M | $28.2M | ||
| Q1 25 | $5.2M | $29.5M | ||
| Q4 24 | $29.2M | $16.0M | ||
| Q3 24 | $-42.8M | $-8.2M | ||
| Q2 24 | $13.9M | $19.9M | ||
| Q1 24 | $-11.2M | $-45.8M |
| Q4 25 | — | 11.6% | ||
| Q3 25 | 32.6% | 11.8% | ||
| Q2 25 | 35.8% | 11.9% | ||
| Q1 25 | 32.8% | 11.8% | ||
| Q4 24 | 33.0% | 13.8% | ||
| Q3 24 | 31.4% | 14.0% | ||
| Q2 24 | 31.3% | 14.2% | ||
| Q1 24 | 29.7% | 14.3% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | 8.6% | 2.6% | ||
| Q2 25 | 13.6% | 1.5% | ||
| Q1 25 | 9.3% | 1.8% | ||
| Q4 24 | 8.8% | 2.6% | ||
| Q3 24 | 6.7% | 2.0% | ||
| Q2 24 | 7.4% | 2.3% | ||
| Q1 24 | 4.7% | 0.3% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | 2.3% | 1.7% | ||
| Q2 25 | 4.6% | 0.9% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 5.6% | 0.5% | ||
| Q3 24 | -8.4% | -0.3% | ||
| Q2 24 | 2.8% | 0.7% | ||
| Q1 24 | -2.3% | -1.8% |
| Q4 25 | — | $0.34 | ||
| Q3 25 | $0.06 | $0.26 | ||
| Q2 25 | $0.13 | $0.13 | ||
| Q1 25 | $0.03 | $0.14 | ||
| Q4 24 | $0.15 | $0.11 | ||
| Q3 24 | $-0.22 | $-0.04 | ||
| Q2 24 | $0.07 | $0.10 | ||
| Q1 24 | $-0.06 | $-0.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $145.9M | $88.4M |
| 総負債低いほど良い | $1.3B | $2.5B |
| 株主資本純資産 | $9.2M | $1.9B |
| 総資産 | $1.8B | $6.4B |
| 負債/資本比率低いほどレバレッジが低い | 141.83× | 1.34× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $88.4M | ||
| Q3 25 | $145.9M | $140.3M | ||
| Q2 25 | $100.7M | $70.1M | ||
| Q1 25 | $71.5M | $52.3M | ||
| Q4 24 | $84.3M | $61.3M | ||
| Q3 24 | $78.5M | $36.0M | ||
| Q2 24 | $47.7M | $25.0M | ||
| Q1 24 | $42.6M | $58.0M |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.3B | $2.5B | ||
| Q2 25 | $1.3B | $2.5B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $1.3B | $2.7B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.3B | $2.6B |
| Q4 25 | — | $1.9B | ||
| Q3 25 | $9.2M | $1.8B | ||
| Q2 25 | $-12.0M | $1.7B | ||
| Q1 25 | $-100.1M | $1.7B | ||
| Q4 24 | $-123.6M | $1.6B | ||
| Q3 24 | $-156.4M | $1.6B | ||
| Q2 24 | $-119.0M | $1.6B | ||
| Q1 24 | $-136.3M | $1.6B |
| Q4 25 | — | $6.4B | ||
| Q3 25 | $1.8B | $6.0B | ||
| Q2 25 | $1.8B | $5.9B | ||
| Q1 25 | $1.7B | $5.8B | ||
| Q4 24 | $1.7B | $5.9B | ||
| Q3 24 | $1.6B | $5.8B | ||
| Q2 24 | $1.7B | $5.6B | ||
| Q1 24 | $1.6B | $5.7B |
| Q4 25 | — | 1.34× | ||
| Q3 25 | 141.83× | 1.38× | ||
| Q2 25 | — | 1.45× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 1.63× | ||
| Q1 24 | — | 1.64× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $33.2M | $231.6M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $193.9M |
| FCFマージンFCF / 売上 | — | 5.5% |
| 設備投資強度設備投資 / 売上 | — | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 2.36× | 3.00× |
| 直近12ヶ月FCF直近4四半期 | — | $394.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $231.6M | ||
| Q3 25 | $33.2M | $107.9M | ||
| Q2 25 | $51.6M | $49.1M | ||
| Q1 25 | $-8.6M | $101.6M | ||
| Q4 24 | $13.4M | $90.6M | ||
| Q3 24 | $29.4M | $27.2M | ||
| Q2 24 | $1.8M | $-15.2M | ||
| Q1 24 | $-12.0M | $-78.9M |
| Q4 25 | — | $193.9M | ||
| Q3 25 | — | $92.2M | ||
| Q2 25 | — | $24.7M | ||
| Q1 25 | — | $84.0M | ||
| Q4 24 | — | $75.3M | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $-39.0M | ||
| Q1 24 | — | $-100.7M |
| Q4 25 | — | 5.5% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | -3.9% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | — | 3.00× | ||
| Q3 25 | 2.36× | 1.93× | ||
| Q2 25 | 1.91× | 1.74× | ||
| Q1 25 | -1.66× | 3.44× | ||
| Q4 24 | 0.46× | 5.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.13× | -0.76× | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
